Mesenchymal Epithelial Transition Inhibitors [MoA] - N0000193929

Pharmacologic Code	N0000193929
Pharmacologic Name	Mesenchymal Epithelial Transition Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Mesenchymal Epithelial Transition Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0078-0709	Tabrecta	Non-Proprietary Name: Capmatinib	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
	0078-0716	Tabrecta	Non-Proprietary Name: Capmatinib	Tablet, Film Coated	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
	44087-5000	Tepmetko	Non-Proprietary Name: Tepotinib Hydrochloride	Tablet	Oral	Emd Serono, Inc.	ACTIVE